These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 19081414

  • 1. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
    Bertrand OF, Larose E, Rodés-Cabau J, Gleeton O, Taillon I, Roy L, Poirier P, Costerousse O, Larochellière RD.
    Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
    [Abstract] [Full Text] [Related]

  • 2. Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes.
    Tizón-Marcos H, Bertrand OF, Rodés-Cabau J, Larose E, Gaudreault V, Bagur R, Gleeton O, Courtis J, Roy L, Poirier P, Costerousse O, De Larochellière R.
    Am Heart J; 2009 Apr; 157(4):740-5. PubMed ID: 19332204
    [Abstract] [Full Text] [Related]

  • 3. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.
    Bertrand OF, Larose E, Rodés-Cabau J, Rinfret S, Déry JP, Bagur R, Gleeton O, Nguyen CM, Proulx G, De Larochellière R, Poirier P, Costerousse O, Roy L.
    Am J Cardiol; 2010 Jul 15; 106(2):155-61. PubMed ID: 20598996
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 5. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
    Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Bagur R, Proulx G, Gleeton O, Costerousse O, De Larochellière R, Roy L.
    Am J Cardiol; 2009 Nov 01; 104(9):1235-40. PubMed ID: 19840568
    [Abstract] [Full Text] [Related]

  • 6. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J, Horlick E, Ivanov J, Seidelin PH, Ross JR, Ing D, Daly P, Mackie K, Ridley B, Schwartz L, Barolet A, Dzavík V.
    Am Heart J; 2008 Nov 01; 156(5):864-70. PubMed ID: 19061699
    [Abstract] [Full Text] [Related]

  • 7. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
    Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, Ben-Dor I, Iakobishvili Z, Rechavia E, Battler A, Assali A.
    Cardiovasc Revasc Med; 2009 Nov 01; 10(2):88-93. PubMed ID: 19327670
    [Abstract] [Full Text] [Related]

  • 8. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction.
    Yan ZX, Zhou YJ, Zhao YX, Liu YY, Shi DM, Guo YH, Cheng WJ.
    Chin Med J (Engl); 2008 May 05; 121(9):782-6. PubMed ID: 18701040
    [Abstract] [Full Text] [Related]

  • 9. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
    Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, Hanson AC, Schroeder DR, Oliver WC, Holmes DR, Rihal CS.
    Anesthesiology; 2008 Oct 05; 109(4):588-95. PubMed ID: 18813036
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):408-15. PubMed ID: 19360863
    [Abstract] [Full Text] [Related]

  • 11. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH, Hao QQ, Jia XW, Fan WZ, Gu XS, Wu WL, Hao GZ, Li SQ, Jiang YF, Geng W.
    Chin Med J (Engl); 2008 Mar 20; 121(6):522-7. PubMed ID: 18364139
    [Abstract] [Full Text] [Related]

  • 12. Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.
    Bagur R, Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Tizón-Marcos H, Gleeton O, Nguyen CM, Roy L, Costerousse O, De Larochellière R.
    Am J Cardiol; 2009 Sep 01; 104(5):624-9. PubMed ID: 19699334
    [Abstract] [Full Text] [Related]

  • 13. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, CREDO Investigators.
    Am Heart J; 2009 Feb 01; 157(2):369-74. PubMed ID: 19185647
    [Abstract] [Full Text] [Related]

  • 14. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Jun 01; 101(11):1544-9. PubMed ID: 18489931
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.
    Am J Cardiol; 2008 Dec 15; 102(12):1618-23. PubMed ID: 19064015
    [Abstract] [Full Text] [Related]

  • 16. Transradial primary angioplasty and stenting in Indian patients with acute myocardial infarction: acute results and 6-month follow-up.
    Ranjan A, Patel TM, Shah SC, Malhotra H, Patel R, Vayada N, Pothiwala R, Fonseca K, Tanwar NS.
    Indian Heart J; 2005 Dec 15; 57(6):681-7. PubMed ID: 16521638
    [Abstract] [Full Text] [Related]

  • 17. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q, Zhang RY, Shen J, Zhang JS, Hu J, Yang ZK, Zhang X, Zheng AF, Shen WF.
    Chin Med J (Engl); 2008 Dec 05; 121(23):2379-83. PubMed ID: 19102952
    [Abstract] [Full Text] [Related]

  • 18. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, O'Neill WW, Grines CL.
    J Am Coll Cardiol; 2004 May 19; 43(10):1773-9. PubMed ID: 15145098
    [Abstract] [Full Text] [Related]

  • 19. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
    Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Büttner HJ, Neumann FJ.
    J Am Coll Cardiol; 2006 Nov 07; 48(9):1742-50. PubMed ID: 17084243
    [Abstract] [Full Text] [Related]

  • 20. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.
    Ko DT, Yun L, Wijeysundera HC, Jackevicius CA, Rao SV, Austin PC, Marquis JF, Tu JV.
    Circ Cardiovasc Interv; 2010 Apr 07; 3(2):140-7. PubMed ID: 20332382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.